Korean Circ J.  2004 Sep;34(9):913-918. 10.4070/kcj.2004.34.9.913.

Endovascular Drug-Coated Stenting of Basilar Artery Stenosis: A Case Report and Literature Review

Affiliations
  • 1Cardiology Division, Yonsei Cardiovascular Center, Yonsei University College of Medicine, Seoul, Korea. whshim@yumc.yonsei.ac.kr
  • 2Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Korea.
  • 3Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
  • 4Department of Diagnostic Radiology, Yonsei University College of Medicine, Seoul, Korea.
  • 5Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.

Abstract

Patients with a symptomatic basilar artery stenosis have a poor prognosis and limited therapeutic options. Despite the best medical efforts, there is still a high incidence of stroke. A surgical bypass is technically demanding with a high mortality and morbidity rate. Percutaneous angioplasty still carries a risk of procedure related complication and restenosis. Stenting has been shown to improve the safety and durability of angioplasty in the coronary and peripheral arteries. Recently, stenting of the intracranial arteries has been attempted by some investigators with newer and more trackable stents. We report a case of a basilar artery stenosis that was successfully treated using a drug-coated stent.

Keyword

Angioplasty; Stents; Basilar artery

MeSH Terms

Angioplasty
Arteries
Basilar Artery*
Drug-Eluting Stents
Humans
Incidence
Mortality
Prognosis
Research Personnel
Stents*
Stroke
Vertebrobasilar Insufficiency*

Cited by  1 articles

An update on interventional revascularization therapy of intracranial arterial steno-occlusive diseases
Deok Hee Lee
J Korean Med Assoc. 2012;55(9):869-877.    doi: 10.5124/jkma.2012.55.9.869.

Full Text Links
  • KCJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr